The presence of the ApoE4 allele bears a major resistance issue to ketogenic interventions against cognitive deterioration in MCI and AD; however, it is still possible to obtain ketogenic cognitive benefits in heterozygous carriers when mixed with lifestyle modifications [38] and double ketogenic approaches [39]. Here, APOE is linked to Alzheimer disease.